ASCO Daily News

101 Jaksot

1. New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

   Julkaistiin: 21.3.2024
2. Innovations in CAR T-Cell Therapy for Multiple Myeloma

   Julkaistiin: 7.3.2024
3. ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity

   Julkaistiin: 15.2.2024
4. Advances in Precision Oncology for GI Cancers at GI24

   Julkaistiin: 8.2.2024
5. Key Advances in Prostate, Kidney, and Bladder Cancers at GU24

   Julkaistiin: 6.2.2024
6. What’s New in Prostate Cancer, RCC, and mUC at GU24

   Julkaistiin: 22.1.2024
7. Celebrating 20 Years of Evolution in GU Oncology

   Julkaistiin: 14.12.2023
8. What the FDA CAR T-Cell Therapy Investigation Means for Oncologists

   Julkaistiin: 7.12.2023
9. Managing the Complexities of Oncology Practice in 2024

   Julkaistiin: 7.12.2023
10. Solutions and Key Research to Advance High-Quality Cancer Care

    Julkaistiin: 9.11.2023
11. How to Implement Universal Germline Testing for CRC

    Julkaistiin: 2.11.2023
12. Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy

    Julkaistiin: 12.10.2023
13. Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer

    Julkaistiin: 28.9.2023
14. ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

    Julkaistiin: 17.8.2023
15. How Oncologists Are Confronting the Cancer Drug Shortage

    Julkaistiin: 10.8.2023
16. AI Will Allow Doctors to Reclaim Time With Patients

    Julkaistiin: 3.8.2023
17. Managing the Side Effects of Endocrine Therapy for Breast Cancer

    Julkaistiin: 27.7.2023
18. The Emergence of Triplet Therapies in ccRCC in the Frontline Setting

    Julkaistiin: 13.7.2023
19. Novel Therapies in GI Oncology at ASCO23

    Julkaistiin: 28.6.2023
20. THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23

    Julkaistiin: 27.6.2023